Dorzolamide is a carbonic anhydrase inhibitor used in ophthalmic (eye) drops to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. By decreasing the production of fluid in the eye, dorzolamide helps to prevent damage to the optic nerve and vision loss associated with elevated IOP.
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide / Dorzolamide Hydrochloride
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
![Dorzolamide Maleic Ester [(n-1)adduct]](https://veeprho.com/wp-content/uploads/2022/07/Dorzolamide-Maleic-Ester-5Bn-1adduct5D.png "Dorzolamide Maleic Ester [(n-1)adduct]")
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
Parent: Dorzolamide
![(4R,6R)-4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran 7,7-dioxide](https://veeprho.com/wp-content/uploads/2023/05/4R-6R-4-hydroxy-6-methyl-5-6-dihydro-4H-thieno-2-3-b-thiopyran-7-7-dioxide.png "(4R,6R)-4-hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran 7,7-dioxide")
Parent: Dorzolamide
Parent: Dorzolamide
![(4S,6R)-5,6-Dihydro-4-hydroxy-6-Methylthieno[2,3-b]thiopyran-7,7-dioxide](https://veeprho.com/wp-content/uploads/2023/05/4S-6R-5-6-Dihydro-4-hydroxy-6-Methylthieno-2-3-b-thiopyran-7-7-dioxide.png "(4S,6R)-5,6-Dihydro-4-hydroxy-6-Methylthieno[2,3-b]thiopyran-7,7-dioxide")
Parent: Dorzolamide
![(4S,6S)-4-Hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide](https://veeprho.com/wp-content/uploads/2023/05/4S-6S-4-Hydroxy-6-methyl-5-6-dihydro-4H-thieno-2-3-b-thiopyran-7-7-dioxide.png "(4S,6S)-4-Hydroxy-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-7,7-dioxide")
Parent: Dorzolamide
Impurities in dorzolamide may arise during its synthesis, storage, or handling, which can affect its quality, stability, and safety.
Related Substances
These are byproducts or intermediates formed during the manufacturing process. Regulatory guidelines ensure that these impurities remain within safe limits.
Degradation Products
Exposure to light, heat, or moisture can lead to the degradation of dorzolamide, reducing its effectiveness. Proper storage in a cool, dry place is essential to maintain its stability.
Residual Solvents
Trace amounts of solvents used during the synthesis may remain in the final product. These are regulated to ensure they are within acceptable safety thresholds.
Analytical Techniques for Monitoring Impurities
Techniques like High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) are used to identify and quantify impurities in dorzolamide formulations.
Dorzolamide is a carbonic anhydrase inhibitor, which is used in eye drops to reduce intraocular pressure in conditions like open-angle glaucoma and ocular hypertension.
Dorzolamide works by inhibiting the enzyme carbonic anhydrase in the ciliary processes of the eye. This decreases the production of aqueous humor (the fluid in the eye), thereby lowering intraocular pressure.
No, dorzolamide and brimonidine are different medications. While dorzolamide is a carbonic anhydrase inhibitor, brimonidine is an alpha-2 adrenergic receptor agonist. Both are used to reduce intraocular pressure, but they work through different mechanisms.
Dorzolamide is a carbonic anhydrase inhibitor that reduces fluid production in the eye, while latanoprost is a prostaglandin analog that increases the outflow of aqueous humor. Both drugs are used to lower intraocular pressure but have different mechanisms of action.
